KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Current Leases (2016 - 2018)

Gsk has reported Current Leases over the past 3 years, most recently at $30.9 million for Q4 2018.

  • For Q4 2018, Current Leases rose 1.13% year-over-year to $30.9 million; the TTM value through Dec 2018 reached $30.9 million, up 1.13%, while the annual FY2018 figure was $32.1 million, 4.97% up from the prior year.
  • Current Leases for Q4 2018 was $30.9 million at Gsk, up from $30.5 million in the prior quarter.
  • Over five years, Current Leases peaked at $30.9 million in Q4 2018 and troughed at $28.6 million in Q4 2016.
  • A 3-year average of $30.0 million and a median of $30.5 million in 2017 define the central range for Current Leases.
  • Biggest five-year swings in Current Leases: increased 6.79% in 2017 and later grew 1.13% in 2018.
  • Year by year, Current Leases stood at $28.6 million in 2016, then grew by 6.79% to $30.5 million in 2017, then rose by 1.13% to $30.9 million in 2018.
  • Business Quant data shows Current Leases for GSK at $30.9 million in Q4 2018, $30.5 million in Q4 2017, and $28.6 million in Q4 2016.